Carcinoma of the Gallbladder and Bile Ducts

  • K. Schoppmeyer
  • K. Caca
  • J. Mössner


Biliary tract cancers are rare tumors that have a poor prognosis. Predisposing conditions are characterized by chronic inflammatory and proliferative stimuli of the biliary epithelium. Despite a wealth of diagnostic tools, these cancers are often detected late due to their insidious symptomatic appearance. In patients with localized cancer, surgery is the only curative treatment option. In hilar bile duct tumors, an extended operation including partial hepatectomy may improve long-term outcome. Currently, there is no adjuvant or palliative radio- or chemotherapy available that has been shown to be effective. Treatment in patients with severe comorbidities or advanced stages of disease is directed towards palliation of symptoms. Endoscopic interventions like biliary decompression play a central role in palliative concepts. Prognosis is determined by disease stage and effective prevention of complications, prominent among them being cholangitis.


Bile Duct Primary Sclerosing Cholangitis Partial Hepatectomy Gallbladder Cancer Hepatic Duct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6–29PubMedCrossRefGoogle Scholar
  2. 2.
    Broome U, Olsson R, Loof L et al. (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38:610–615PubMedCrossRefGoogle Scholar
  3. 3.
    Holzinger F, Z’graggen K, Büchler MW (1999) Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangio-carcinoma. Ann Oncol 10 Suppl 4:122–126PubMedCrossRefGoogle Scholar
  4. 4.
    Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar choangiocarcinoma. Ann Surg 215:31–38PubMedCrossRefGoogle Scholar
  5. 5.
    Shah SK, Mutignani M, Costamagna G (2002) Therapeutic biliary endoscopy. Endoscopy 34:43–53PubMedCrossRefGoogle Scholar
  6. 6.
    Jarnagin WR, Fong Y, DeMatteo RP et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234: 507–519PubMedCrossRefGoogle Scholar
  7. 7.
    Pitt HA, Nakeeb A, Abrams RA et al. (1995) Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival. Ann Surg 221: 778–797CrossRefGoogle Scholar
  8. 8.
    Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34:977–986PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • K. Schoppmeyer
    • 1
  • K. Caca
    • 1
  • J. Mössner
    • 1
  1. 1.Medizinische Klinik und Poliklinik IIUniversitätsklinikum LeipzigLeipzigGermany

Personalised recommendations